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Abstract: OBJECTIVES To test whether block bone substitute used for guided bone regeneration (GBR)
of peri-implant defects leads to different thickness of the augmented hard tissue than particulate bone
substitute. MATERIAL AND METHODS In 24 patients, 24 two-piece dental implants were placed
>4 months after tooth extraction. Following random allocation, 12 peri-implant bone dehiscences were
grafted with an individually shaped block of deproteinized bovine-derived bone mineral (DBBM) and 12
bone dehiscences with particulate DBBM. All the sites were covered with a collagen membrane stabilized
with resorbable pins. Immediately after wound closure and after 6 months, the horizontal thickness (HT)
of the augmented hard tissue was measured at the level of implant shoulder using cone beam-computed
tomography. RESULTS After wound closure, the median HT measured 3.35 mm (mean: 3.38) in the
block group and 2.85 mm (mean: 2.73) in the particulate group. At 6 months, the median HT decreased
to 2.90 mm (mean: 2.71) in the block group and to 0.2 mm (mean: 0.52) in the particulate group.
This difference was statistically significant (p < .001). CONCLUSIONS Block bone substitute used for
GBR of peri-implant defects was superior to particulate bone substitute regarding the dimension of the
augmented hard tissue after 6 months of healing.
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Objectives: To test whether block bone substitute used for guided bone 
regeneration (GBR) of peri-implant defects leads to different thickness of the augmented 
hard tissue than particulate bone substitute. 
Material & Methods: In 24 patients, 24 two-piece dental implants were placed >4 
months after tooth extraction. Following random allocation, 12 peri-implant bone 
dehiscences were grafted with an individually shaped block of deproteinized bovine-derived 
bone mineral (DBBM) and 12 bone dehiscences with particulate DBBM. All the sites were 
covered with a collagen membrane stabilized with resorbable pins. Immediately after wound 
closure and after 6 months, the horizontal thickness (HT) of the augmented hard tissue was 
measured at the level of implant shoulder using cone beam computed tomography. 
Results: After wound closure, the median HT measured 3.35 mm (mean: 3.38) in 
the block group and 2.85 mm (mean: 2.73) in the particulate group. At 6 months, the median 
HT decreased to 2.90 mm (mean: 2.71) in the block group and to 0.2 mm (mean: 0.52) in 
the particulate group. This difference was statistically significant (p<0.001). 
Conclusions: Block bone substitute used for GBR of peri-implant defects was 
superior to particulate bone substitute regarding the dimension of the augmented hard tissue 
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Introduction 
Guided bone regeneration (GBR) with particulate bone substitutes in combination 
with collagen membranes (CM) is currently the most widely used and best documented 
method for bone augmentation of peri-implant defects. Numerous short-term (Benic, Jung, 
Siegenthaler, Hammerle, 2009; Mayfield, Skoglund, Nobreus, Attstrom, 1998; Zitzmann, 
Scharer, Marinello, 2001; Zumstein, Billstrom, Sennerby, 2012) and two recent long-term 
controlled clinical trials (Benic, Bernasconi, Jung, Hammerle, 2017a; Jung, Fenner, 
Hammerle, Zitzmann, 2013) document that implants placed simultaneously with GBR 
perform similarly to implants completely placed into pristine bone with respect to implant 
survival and interproximal bone levels. Previous cone beam computed tomographic (CBCT) 
investigations of peri-implant defects treated with particulate deproteinized bovine-derived 
bone mineral (DBBM) with CM found well-maintained levels of the augmented buccal bone 
after 5-9 years (Buser, et al., 2013; Jung, Benic, Scherrer, Hammerle, 2015). Moreover, a 
recent 15-year follow-up clinical investigation with intra-subject control found no differences 
in the dimension of the buccal bone between implants placed simultaneously with GBR 
using particulate DBBM and CM compared to implants placed completely into pristine bone 
(Benic, et al., 2017a). 
The main shortcoming of GBR with particulate bone graft in combination with CM is 
their lack of morphological stability often leading to partial loss of the augmented space. 
These materials cannot well withstand the soft tissue pressure and compression of the 
augmented site may result in a displacement of the bone substitute material (Mellonig, 
Nevins, Sanchez, 1998; Mir-Mari, Benic, Valmaseda-Castellon, Hammerle, Jung, 2017; Mir-
Mari, Wui, Jung, Hammerle, Benic, 2016; Schwarz, et al., 2007; Strietzel, Khongkhunthian, 
Khattiya, Patchanee, Reichart, 2006). Consequently, the use of particulate bone substitute 
and CM is not optimal for the augmentation of deficient ridge contours (Benic, Hammerle, 
2014). 
Bone grafts in block form offer improved mechanical support to the covering 
membrane and the overlying mucosa. Hence, they may lead to better results regarding the 
augmentation of ridge contours. Previous investigations of bone block substitutes focused 
on primary ridge augmentations. It was shown that DBBM blocks or equine-derived bone 
mineral blocks lead to successful horizontal ridge augmentation in both experimental and 
clinical studies (Araujo, Sonohara, Hayacibara, Cardaropoli, Lindhe, 2002; De Santis, et al., 
2012; Hammerle, Jung, Yaman, Lang, 2008; Schwarz, et al., 2010; Schwarz, Mihatovic, 
Ghanaati, Becker, 2017; Schwarz, et al., 2008). 
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deficient ridge contours simultaneously with implant placement (Benic, et al., 2017b; Benic, 
et al., 2016; Mir-Mari, et al., 2016). An in-vitro trial investigated the dimensional stability of 
the regions augmented with GBR during wound closure (Mir-Mari, et al., 2016). It was found 
that flap suturing induced a considerable amount of particulate DBBM displacement 
resulting in a reduction of the horizontal thickness of the augmented site. In contrast, the 
sites augmented with DBBM blocks exhibited less thickness reduction. On average, the use 
of block instead of particulate DBBM reduced the amount of thickness reduction at the level 
of the implant shoulder by more than 50%. A similar beneficial effect was achieved by fixing 
the membrane with resorbable pins (Mir-Mari, et al., 2016). Based on these in-vitro 
experiments the in-vivo performance of collagen-containing equine blocks, of DBBM blocks 
and of particulate DBBM for GBR with simultaneous implant placement was investigated in a 
recent preclinical study (Benic, et al., 2017b; Benic, et al., 2016). All the grafting materials 
were applied in combination with CM for the augmentation of box-shaped peri-implant 
defects. After 4 months of healing, the equine block rendered the most favorable outcomes 
in hard and soft tissue ridge contours followed by the DBBM block and the particulate 
DBBM. 
The primary aim of the present clinical trial was to test whether DBBM block used for 
GBR of peri-implant defects leads to different thickness of the augmented hard tissue than 
particulate DBBM. The results of the histological analysis of the augmented hard tissue will 
be presented in a subsequent publication. 
 
Materials and methods 
This article was prepared according to the CONSORT guidelines for reporting 
parallel group randomized trials (Moher, et al., 2010). 
 
Study design 
This trial was designed as a randomized controlled clinical trial with two parallel 
study groups and a duration period of five years. The study was performed at the Clinic of 
Reconstructive Dentistry, Center of Dental Medicine, University of Zurich, Zurich, 
Switzerland. The trial was approved by the local ethical committee (reference code KEK-ZH 
2011-0075; Kantonale Ethik-Kommission, Zurich, Switzerland) and registered in the German 
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Study population 
Twenty-nine subjects were recruited in need of a dental implant in an edentulous jaw 
region with a buccal deficiency of the alveolar bone. Written informed consent was obtained 
from all the patients prior to the initiation of treatment. 
The subjects had to fulfill the following inclusion criteria: 
 At least 18 years of age  
 No medical history in which any elective oral surgical intervention would be 
contraindicated  
 No heavy smoking (>20 cigarettes per day), no pipe or cigar smoking 
 No active periodontal disease 
 Full-mouth plaque score <25%  
 Need of a dental implant with a concomitant buccal deficiency of the alveolar 
ridge 
 Implant placement >4 months after tooth extraction 
 Presence of a dehiscence-type buccal bone defect after implant placement 
 
Randomization and allocation concealment 
The patients were randomly allocated to one of the two treatment modalities 
according to a computer-generated randomization list. A permuted-block randomization with 
block sizes of 4 and allocation ratio of 1:1 was applied to generate the allocation sequence. 
Allocation to the study groups was concealed by means of sealed envelopes until the time of 
surgical procedure that required GBR of the bone dehiscence.  
 
Treatment procedures and clinical measurements 
The investigators participating in the study were experienced in implant placement 
and bone augmentation procedures. Prior to the study initiation, all investigators attended a 
training session to standardize the patient selection and the treatment procedures and to 
calibrate the assessment techniques. 
Prior to surgery, the patients received antibiotics (2x750 mg amoxicillin) and non-
steroidal analgesics/antiphlogistics. The surgery was performed under local anaesthesia. A 
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elevated. The implant bed was prepared according to the manufacturer’s recommendations 
and a titanium two-piece dental implant (OsseoSpeed EV, DENSTPLY Implants, Mannheim, 
Germany) was inserted in a prosthetically ideal position. The height of the buccal bone 
defect was measured with reference to the implant shoulder by using a calibrated 
periodontal probe. There were 21 one-wall defects and 3 two-wall defects. 
 
The peri-implant bone defects were randomly assigned to receive one of the 
following GBR treatments: 
 Group particulate bone substitute (particulate): particulate deproteinized 
bovine bone mineral (DBBM) (Geistlich Bio-Oss® spongiosa granules, particle 
size 0.25-1mm, Geistlich Pharma AG, Wolhusen, Switzerland) + native 
bilayer collagen membrane (NBCM) (Geistlich Bio-Gide®, Geistlich Pharma 
AG) + resorbable polylactic acid fixation pins (Inion GTRTM, Inion Ltd, 
Tampere, Finland) 
 Group block bone substitute (block): DBBM block (Geistlich BioOss® block, 
Geistlich Pharma AG) + NBCM (Geistlich Bio-Gide®, Geistlich Pharma AG) + 
fixation pins (Inion GTRTM, Inion Ltd). 
Ten out of 12 (83.3%) particulate sites and 11 out of 12 (91.7%) block sites 
presented one-wall defects. The remaining sites had two-wall defects. 
The peri-implant bone defect was filled and the missing ridge contour was built up 
with DBBM without autogenous bone. DBBM blocks were shaped with diamond burs and 
adapted to fit the defect morphology (Fig. 1 and 2). No fixation screws were used. 
Particulate DBBM was applied to over-augment the buccal and the coronal ridge contours. 
The horizontal thickness of the grafting material was measured at the level of the implant 
shoulder by using a periodontal probe. NBCM and DBBM were stabilized by tacking the 
buccal margin of the membrane onto native bone apically to the defect with 2 or 3 fixation 
pins. The oral margin of the membrane was inserted under the oral flap. A periosteal-
releasing incision was performed in the apical region of the buccal flap to allow tension-free 
wound closure. Primary wound closure was obtained with non-resorbable monofilament 
sutures (Gore-Tex®, W.L. Gore & Associates, Flagstaff, AZ, USA). 
The patients were instructed to refrain from mechanical plaque removal in the 
proximity of the surgical site and to rinse the oral cavity twice daily with 0.2% chlorhexidine-
digluconate. Antibiotics were prescribed for 5 days (3x750 mg amoxicillin/day) and 
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7 days after implant placement. Post-surgical visits included inspection of the site of surgery 
and supra-gingival cleaning and were performed 1 and 4 weeks after implant placement. At 
these visits, the soft tissue condition was rated “normal”, “dehisced” or “swollen”. 
No soft tissue grafting was performed following implant placement and GBR. At 6 
months, re-entry surgery was performed by elevating the buccal mucoperiosteal flap and the 
augmented hard tissue was assessed (Fig. 1f and 2g). In the presence of bone dehiscence, 
defect height was measured with reference to the implant shoulder by using a calibrated 
periodontal probe. Cover screws were replaced by healing abutments and the flaps were 
sutured. 
 
CBCT scanning and analysis 
CBCT scans were taken (1) immediately after implant placement and (2) after 6 
months prior to re-entry surgery (Fig. 1-4). CBCT imaging was performed with a 3D 
Accuitomo 170 scanner (J. MORITA EUROPE GMBH, Dietzenbach, Germany). The scans 
were made using the following technical parameters: 90 kV, 5 mA, 87.5 mAs, voxel size of 
125-250 µm, 360° rotation and scanning time of 17.5 sec. 
CBCTs were analyzed by one investigator who was unaware of the specific 
experimental conditions. A bucco-oral cross-section perpendicular to the implant central axis 
was used for the CBCT analysis (i-Dixel 2.0 3D Imaging Software, J. MORITA EUROPE 
GMBH). 
The following parameters were assessed on each CBCT scan: 
 the horizontal thickness of the augmented hard tissue measured from the implant 
shoulder in a buccal direction perpendicular to the implant long axis (HT) (Fig. 5) 
 the thickness of the augmented hard tissue measured from the implant shoulder 
in a bucco-coronal direction at 45 degrees to the implant long axis (45°T) (Fig 5). 
CBCT analysis was performed twice with a 1 week-period between the 
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Statistical analysis  
The primary outcome parameter was the horizontal thickness of the augmented hard 
tissue at 6 months.  
The sample size calculation was based on two independent groups, a normal 
distribution and the two-sample t-test. To detect a difference of 0.5 mm with a standard 
deviation (SD) of 0.5 mm (power: 80%, significance level: 0.05), 17 patients per group (total 
of 34 patients) were required. As no clinical data were available for the same combination of 
materials, the sample size calculation was considered to be of exploratory nature 
The data distributions were represented with boxplots and the data were reported 
with medians, means, standard deviations (SD), interquartile ranges (IQR), and ranges (R 
software; R Foundation, Vienna, Austria). The non-parametric Wilcoxon Mann–Whitney U-
test was applied to detect differences between the groups because of the small size of the 
included sample. Results of tests with p-values ≤ 0.05 were considered statistically 





Twenty-nine patients were recruited for surgery from August 2014 to July 2017. One 
block case and two granulate cases were excluded due to the absence of a dehiscence-type 
bone defect. In one block case the comprehensive treatment plan had to be modified and 
the study site requested an additional surgical intervention leading to the exclusion from the 
study. In one block case the CBCT scanning was not adequately performed. Because of the 
unexpectedly long duration of the recruitment period, in August 2017, it was decided to 
interrupt the patient recruitment. 
Twenty-four patients were included for the analysis. Of these, 12 were randomized to 
the block group and 12 to the particulate group. Patient gender, patient age and implant 
location are reported in Table A1. At 6 months, CBCT examination and re-entry surgery 
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Soft tissue condition 
Two mucosal dehiscences were observed at the time of suture removal. One of 
these occurred in the particulate group and one in the block group. Moreover, at suture 
removal, there was 1 case of swollen mucosa in each group. At 4 weeks and at 6 months, 
the soft tissue condition was rated “normal” in all patients. 
 
Bucco-oral hard tissue changes 
The results of radiographically assessed hard tissue thickness changes are 
presented in Tables 1a and 1b. 
Intraoperatively, the median horizontal thickness of DBBM measured 3 mm 
(mean±SD: 3.17±0.49 mm) in the block group and 4 mm (mean±SD: 4.00±0.74 mm) in the 
particulate group (Table 1a, Fig. 6). 
After wound closure, the median horizontal thickness of the augmented hard tissue 
reached 3.35 mm (mean±SD: 3.38±0.59 mm) in the block group and 2.85 mm (mean±SD: 
2.73 ± 0.69 mm) in the particulate group (Table 1a, Fig. 6). 
At 6 months, the median horizontal thickness of the augmented hard tissue 
amounted to 2.90 mm (mean±SD: 2.71±1.19 mm) in the block group and 0.2 mm 
(mean±SD: 0.52±0.80 mm) in the particulate group (Table 1a, Fig. 6). The difference in HT 
at 6 months between the groups measured 2.7 mm and was statistically significant 
(p<0.001; 95% confidence interval: 1.1 mm; 3.0 mm). 
 
Apico-coronal hard tissue changes 
The median defect height clinically assessed after implant placement measured 3.5 
mm in the block group and 4.25 mm in the particulate group (p=0.749) (Table 2). 
At re-entry surgery, 11 out of 12 (91.7%) block sites and 3 out of 12 (25%) particulate 
sites clinically showed a complete vertical defect fill. The median vertical defect amounted to 
0 mm in the block group and to 0.75 mm in the particulate group (p = 0.001) corresponding 
to median vertical defect resolutions of 100% (mean: 98.6%) and 87% (mean: 80.5%), 
respectively (Table 2). 
In the 6-month CBCT, 12 out of 12 (100%) block sites and 8 out of 12 (66.7%) 
particulate sites showed a complete vertical defect fill. The differences between the 
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Discussion 
 
The results of the present RCT demonstrated that the block of DBBM with NBCM 
was superior to particulate DBBM and NBCM with respect to the thickness of the augmented 
hard tissue after 6 months of healing. DBBM block maintained the augmented space better 
than particulate DBBM. This holds true both during wound closure and over the 6-month 
healing period. 
With respect to the dimensions of the augmented ridge, the results of the present 
clinical trial confirm the findings of the recent proof-of-the-principle in-vitro and in-vivo 
preclinical investigations of individually shaped bone substitute blocks used for the 
augmentation of peri-implant bone defects (Benic, et al., 2017b; Benic, et al., 2016; Mir-Mari, 
et al., 2016). An in-vitro study assessed the horizontal dimensions of block and particulate 
DBBM in combination with CM prior to and after wound closure (Mir-Mari, et al., 2016). In 
this study, the following material combinations for the augmentation of peri-implant defects 
were assessed by means of CBCT: (i) particulate DBBM + NBCM, (ii) particulate DBBM + 
NBCM + fixation pins, and (iii) DBBM block + NBCM. The investigators found that wound 
closure induced a considerable displacement of particulate DBBM resulting in a partial 
collapse of the NBCM. The average reduction in the horizontal thickness at the implant 
shoulder amounted to 40% for particulate DBBM + NBCM without fixation pins. The sites 
augmented with DBBM block + NBCM without pins exhibited an average loss of thickness of 
20% caused by the displacement of the block graft during wound closure. A similar average 
value of 20% in thickness reduction was achieved with particulate DBBM + NBCM + fixation 
pins. In the present clinical study, the sites augmented with particulate DBBM + NBCM + 
fixation pins lost approximately 30% in thickness during wound closure. This result is in 
accordance with the findings from the previous in-vitro CBCT study. On the other side, in the 
present study the sites augmented with DBBM block + NBCM + fixation pins were able to 
maintain the space during flap suturing. The difference between this finding and the results 
of the previous in-vitro CBCT study can be explained by the use of fixation pins in this 
clinical trial. A recent preclinical study assessed the in-vivo performance of a collagen-
containing equine block, of a DBBM block and of particulate DBBM used for GBR with 
simultaneous implant placement (Benic, et al., 2017b). All the grafting materials were 
applied with CM without fixation pins for the augmentation of large peri-implant defects. After 
4 months of healing, the equine block rendered the most favorable outcomes regarding hard 
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performance of block bone substitutes over particulate grafting material for the augmentation 
of deficient ridge contours was showed in another comparative preclinical trial (Schwarz, et 
al., 2008).  
 
The use of individually shaped bone substitute blocks for the augmentation of peri-
implant defects was assessed in a recent clinical study (Amorfini, Migliorati, Signori, 
Silvestrini-Biavati, Benedicenti, 2014). In this split-mouth RCT corticocancellous allograft 
blocks covered with CM were compared to a mixture of particulate DBBM and autogenous 
bone with CM. Osteosynthesis screws were used in both groups to stabilize the grafting 
materials. The variation of the hard tissue volume was measured by superimposing the 
preoperative CBCT with the CBCT taken after 1 year of healing. The block allograft and the 
particulate graft showed similar results regarding the augmented bone volume (Amorfini, et 
al., 2014). Due to the differences in the regions-of-interest and the outcome variables used 
for the assessment, the results from the investigation of the allograft block cannot be 
compared to the results of the present trial. In fact, in the previous RCT the entire volume of 
the augmented region was measured in mm3, whereas in the present study the bucco-oral 
thickness of the augmented ridge was assessed specifically at the level of the implant 
shoulder. Another RCT assessed the horizontal hard tissue changes 6 months after 
augmentation of peri-implant defects with particulate DBBM (Naenni, et al., 2017). In 27 
patients, 27 dental implants were placed in single-tooth gaps in the anterior and premolar 
area. The implants were placed at least 6 weeks after tooth extraction corresponding either 
to type 2, type 3 or type 4 procedures (Hammerle, Chen, Wilson, 2004). Buccal dehiscence 
and/or fenestration-type defects were augmented with particulate DBBM randomly covered 
either with a NBCM or a titanium-reinforced non-resorbable membrane. Tacks for the 
membrane fixation were used in both groups. The bucco-oral thickness of the augmented 
region was clinically measured during the surgical intervention and at re-entry surgery 6 
month later. The mean horizontal thickness after augmentation measured 3.5 mm for the 
NBCM group. At re-entry, this value decreased to 1.3 mm on average. The considerable 
horizontal change at the level of the implant shoulder after 6 month reported by these 
investigators is in agreement with the observations from the present trial. However, in the 
present study the thickness reduction for the group particulate + NBCM + pins was more 
pronounced. The difference in the values of hard tissue thickness may be explained by 
different assessment modalities and time points of implant placement after tooth extraction. 
In particular, the previous study included the type 2 implant placement time point, which 
probably more often lead to contained 2-wall defects with less exposure to the pressure of 
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tooth extraction and the majority of the peri-implant defects were poorly contained 1-wall 
defects.  
In the present study, at re-entry surgery, 11 out of 12 block sites and 3 out of 12 
particulate sites clinically showed a complete vertical defect fill. This translated into 98.6% 
and 80.5% of mean vertical defect resolution in the block and particulate group, 
respectively. The dimensions of the remaining bone defects at re-entry ranged from 0.5 to 1 
mm. In the previously mentioned RCT comparing CM and non-resorbable membranes in 
combination with particulate DBBM, 6 out of 13 sites with CM demonstrate incomplete 
vertical regeneration (Naenni, et al., 2017). The vertical defect resolution for particulate 
DBBM + CM + pins after 6 months amounted to 85%. Previous clinical studies with a similar 
design found dehiscence defect resolution for the combination of particulate DBBM and CM 
ranging from 91% to 96% (Jung, et al., 2003; Jung, Halg, Thoma, Hammerle, 2009; 
Zitzmann, Naef, Scharer, 1997). A recent systematic review on the efficacy of lateral bone 
augmentation at peri-implant defects included 28 clinical studies mostly using particulate 
xenograft and collagen membrane (Thoma et al., 2019). The meta-analysis rendered a 
mean vertical defect resolution of 81.3% ranging from 56.4% to 97.1%, which is in 
accordance with the results of the present study. 
In the present study, CBCT was used for a standardized assessment of the change 
in the dimension of the augmented region. It is worth noting that the clinical measurement at 
re-entry surgery revealed more sites with remaining bone defects in comparison to the 
corresponding CBCT. At re-entry surgery, 1 out of 12 block sites and 3 out of 12 particulate 
sites showed remaining defect heights ranging from 0.5 to 2 mm. On the other hand, in 
CBCT only 4 particulate sites exhibited incomplete defect fill. The discrepancy between the 
clinical observation after flap elevation and the CBCT assessment can be explained by the 
DBBM particles within the mucosal flaps.  
The results of the present investigations indicated that the use of block bone 
substitutes was more predictable than particulate grafting materials for a complete vertical 
defect fill and the contour augmentation at peri-implant bone defects. The use of customized 
bone substitute blocks for the augmentation of uncontained peri-implant bone defects has, 
therefore, the potential to eliminate the need for the use of non-resorbable materials, such 
as membranes, meshes or tenting screws. The results of this study demonstrate that the 
mechanical stability of a grafting material plays a significant role during wound closure as 
well as during the healing period. Due to the low sample size the results of the present 6-
month investigation need to be interpreted with caution. Future long-term controlled clinical 
studies with baseline and follow-up measurements are needed to confirm or refute the 
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Conclusions 
Within the limitations of the present preliminary analysis, it can be concluded that for 
GBR of poorly contained peri-implant defects: 
 A block bone substitute in combination with a collagen membrane and 
fixation pins was superior to a particulate bone substitute with a collagen 
membrane and fixation pins with respect to the thickness of the augmented 
hard tissue after 6 months of healing. 
 Despite the use of pins for membrane stabilization, considerable 
displacement of the particulate grafting material occurs both during flap 
suturing and during the subsequent healing period. 
 The sites augmented with a block bone substitute exhibited less contour loss 
during wound closure and the 6-month healing period in comparison to the 
sites grafted with a particulate DBBM.  
 The use of block bone substitute in combination with a collagen membrane 
was superior to a particulate bone substitute with a collagen membrane 
regarding the vertical bone defect resolution at the 6-month reentry. 
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Table legend 
Table 1a. Results of the horizontal thickness of the augmented hard tissue 
Table 1b. Results of the 45 degree-thickness of the augmented hard tissue 
Table 2. Results of the defect height 
Table A1. Patient demographics and distribution of implant locations. 
 
Figure legend 
Figure 1. (a, b) Bone dehiscence after implant placement. Guided bone regeneration 
with (c) particulate deproteinized bovine-derived bone mineral and (d) collagen membrane 
stabilized with polylactide pins. (e) CBCT bucco-oral images (left) immediately after wound 
closure and (right) after 6 months. (f) Incomplete vertical defect resolution at re-entry 
surgery, 6 months after implant placement.  
Figure 2. (a, b) Bone dehiscence after implant placement. Guided bone regeneration 
with (c, d) an individually shaped block of deproteinized bovine-derived bone mineral and (e) 
collagen membrane stabilized with polylactide pins. (f) CBCT bucco-oral images (left) 
immediately after wound closure and (right) after 6 months. (g) Complete defect resolution 
and well maintained ridge contour at re-entry surgery, 6 months after implant placement.  
Figure 3. CBCT bucco-oral images (left) immediately after wound closure and (right) 
6 months after implant placement and GBR with an individually shaped block of 
deproteinized bovine-derived bone mineral and collagen membrane stabilized with 
polylactide pins (a) in the maxillary front and (b) in the maxillary premolar region. 
Figure 4. CBCT bucco-oral images (left) immediately after wound closure and (right) 
6 months after implant placement and GBR with particulate deproteinized bovine-derived 
bone mineral and collagen membrane stabilized with polylactide pins (a) in the maxillary 
front and (b) in the maxillary premolar region. 
Figure 5. Horizontal thickness of the augmented hard tissue measured from the 
implant shoulder in a buccal direction (HT), and thickness of the augmented hard tissue 
measured in a bucco-coronal direction at 45 degrees to the implant long axis (45°T). 
Figure 6. Boxplots representing the horizontal thickness of the augmented hard 
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    Block (n=12)         Particulate (n=12)       p-value* 
    Median Mean ± SD IQR Min Max   Median Mean ± SD IQR Min Max   
Intraoperative                         
  HT (mm) 3 3.17±0.49 0.5 2 4   4 4.00±0.74 0.5 3 5 0.007✝ 
Postoperative                         
  HT (mm) 3.35 3.38±0.59 0.7 2.4 4.3   2.85 2.73±0.69 0.5 1.2 4 0.017✝ 
6 months                         
  HT (mm) 2.90 2.71±1.19 0.8 0.2 4.2   0.2 0.52±0.80 0.5 0 2.4 <0.001✝ 
Change intraop-postop                       
  HT (mm) 0.25 0.22±0.45 0.6 -0.5 0.8   -1.1 -1.27±1.1 1.8 -3 0 <0.001✝ 
  HT (%) 7.85 7.5±14.0 22.2 -13.3 26.7   -27.5 -28.9±23.2 32.7 -70.0 0 <0.001✝ 
Change postop-6m                         
  HT (mm) -0.4 -0.68±0.82 0.6 -2.5 -0.1   -2.35 -2.21±0.98 1.3 -4 -0.6 <0.001✝ 
  HT (%) -11.9 -22.5±30.9 13.8 -91.7 -2.3   -92.7 -81.8±27.4 20.8 -100 -20 <0.001✝ 
*, Results of Mann-Whitney test; HT, horizontal thickness of the augmented hard tissue; intraop, intraoperative; postop, postoperative; 6m, 6 months; n, number; SD, standard 
deviation; IQR, interquartile range; Min, minimum; Max, maximum; ✝, statistically significant 
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    Block (n=12)         Particulate (n=12)       p-value* 
    Median Mean ± SD IQR Min Max   Median Mean ± SD IQR Min Max   
Postoperative                         
  45°T (mm) 2.35 2.46±0.58 0.95 1.7 3.3   2.1 1.98±0.70 0.28 0.7 3.4 0.145 
6 months                         
  45°T (mm) 1.75 1.61±0.93 1.5 0.1 2.8   0 0.33±0.65 0.2 0 1.8 <0.001✝ 
Change postop-6m                         
  45°T (mm) -0.8 -0.85±0.61 1.1 -1.8 0   -1.9 -1.64±0.82 1.1 -3.2 -0.3 0.014✝ 
  45°T (%) -29.4 -38.1±32.0 35.3 -94.7 0   -100 -84.6±28.3 15.1 -100 -14.3 0.002✝ 
*, Results of Mann-Whitney test; 45°T, 45 degree-thickness of the augmented hard tissue; postop, postoperative; 6m, 6 months; ; n, number, SD, standard deviation, IQR, 
interquartile range; Min, minimum; Max, maximum; ✝, statistically significant 
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    Block (n=12)         Particulate (n=12)       p-value* 
    Median Mean ± SD IQR Min Max   Median Mean ± SD IQR Min Max   
Intraoperative                         
  Defect height (mm) 3.5 4.54±2.50 4.1 2 9   4.25 4.58±2.12 2.5 2 8 0.749 
6 months                         
  Defect height (mm) 0 0.04±0.14 0 0 0.5   0.75 0.75±0.62 0.6 0 2 0.001✝ 
Change intraop-6 months                         
  Defect height resolution (%) 100 98.6±4.8 0 83.3 100   86.6 80.5±18.5 31.0 50 100 0.002✝ 
*, Results of Mann-Whitney test;  n, number; SD, standard deviation; IQR, interquartile range; Min, minimum; Max, maximum; ✝, statistically significant 
 


































































































  Block group Particulate group 
Gender (number)     
  Female 7 7 
  Male 5 5 
Age (years)     
  Mean 62.0 58.1 
  Range 43.5 - 78.6 28.7 - 78.8 
  Median 62.8 62.2 
Site (number)     
  Incisive 4 0 
  Canine 0 3 
  Premolar 5 9 
  Molar 3 0 
Jaw (number)     
  Maxilla 7 6 
  Mandible 5 6 
 
Table A1. Patient demographics and distribution of implant locations. 
 
 
